Human count
The studied group is tiny
The FDA found five human studies with about 80 people receiving BPC-157 in total.
Claim sourceFDA briefing document
Evidence cards
What the BPC-157 evidence really shows
The big gap is simple: animal studies are plentiful; useful human trials are not.
Read time: a few calm minutes
Studies with a comparison group
The bowel-disease study did not settle the question
The FDA said a two-week comparison study did not provide enough evidence that BPC-157 works for ulcerative colitis, a bowel disease.
Claim sourceFDA briefing document
Injury claims
The positive tendon work is in animals
A review counted 36 bone, joint and muscle studies: 35 were preclinical, meaning they were not human treatment trials, and one was a human report.
Claim sourceMusculoskeletal review on PubMed
New trials
Registered is not finished
As of September 2026, a hamstring study in China comparing BPC-157 with a dummy treatment was still signing up volunteers. A small United States shoulder study had not started. Neither had results yet.
Claim sourceClinicalTrials.gov records
Bottom line
“Promising” is not a result
When an offer uses that word, ask which completed human comparison supports the exact claim.
End of this page. A list of every page in this guide is just below.